Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk
View ORCID ProfileErnst Mayerhofer, View ORCID ProfileRainer Malik, View ORCID ProfileLivia Parodi, View ORCID ProfileStephen Burgess, View ORCID ProfileAndreas Harloff, View ORCID ProfileMartin Dichgans, View ORCID ProfileJonathan Rosand, View ORCID ProfileChristopher D Anderson, Marios K Georgakis
doi: https://doi.org/10.1101/2022.03.22.22272697
Ernst Mayerhofer
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
7Department of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
MDRainer Malik
5Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany
PhDLivia Parodi
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
PhDStephen Burgess
6University of Cambridge, MRC Biostatistics Unit, Cambridge United Kingdom
PhDAndreas Harloff
7Department of Neurology and Neurophysiology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Germany
MDMartin Dichgans
5Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany
8German Center for Neurodegenerative Diseases (DZNE, Munich), Munich, Germany
9Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
MDJonathan Rosand
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
MD, MScChristopher D Anderson
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
10Department of Neurology, Brigham and Women’s Hospital, Boston, MA, USA
MD, MMScMarios K Georgakis
1Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA, USA
2Program in Medical and Population Genetics, Broad Institute of Harvard and the Massachusetts Institute of Technology, Boston, MA, USA
3Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, USA
4Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
5Institute for Stroke and Dementia Research (ISD), University Hospital, Ludwig-Maximilians-University (LMU) Munich, Munich, Germany
MD, PhDData Availability
The data that support the findings of this study are available from the UK Biobank and the GWAS for on-statin LDL.
Posted March 23, 2022.
Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk
Ernst Mayerhofer, Rainer Malik, Livia Parodi, Stephen Burgess, Andreas Harloff, Martin Dichgans, Jonathan Rosand, Christopher D Anderson, Marios K Georgakis
medRxiv 2022.03.22.22272697; doi: https://doi.org/10.1101/2022.03.22.22272697
Genetically predicted on-statin LDL response is associated with higher intracerebral hemorrhage risk
Ernst Mayerhofer, Rainer Malik, Livia Parodi, Stephen Burgess, Andreas Harloff, Martin Dichgans, Jonathan Rosand, Christopher D Anderson, Marios K Georgakis
medRxiv 2022.03.22.22272697; doi: https://doi.org/10.1101/2022.03.22.22272697
Subject Area
Subject Areas
- Addiction Medicine (394)
- Allergy and Immunology (706)
- Anesthesia (197)
- Cardiovascular Medicine (2890)
- Dermatology (248)
- Emergency Medicine (433)
- Epidemiology (12634)
- Forensic Medicine (10)
- Gastroenterology (814)
- Genetic and Genomic Medicine (4494)
- Geriatric Medicine (411)
- Health Economics (718)
- Health Informatics (2877)
- Health Policy (1059)
- Hematology (381)
- HIV/AIDS (913)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4264)
- Nursing (228)
- Nutrition (626)
- Oncology (2232)
- Ophthalmology (637)
- Orthopedics (256)
- Otolaryngology (323)
- Pain Medicine (272)
- Palliative Medicine (83)
- Pathology (491)
- Pediatrics (1183)
- Primary Care Research (489)
- Public and Global Health (6845)
- Radiology and Imaging (1505)
- Respiratory Medicine (910)
- Rheumatology (431)
- Sports Medicine (378)
- Surgery (476)
- Toxicology (60)
- Transplantation (206)
- Urology (176)